Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Uterine Cancer 2010 NICHD 5R01HD042311-07 Molecular Analysis of Uterine Receptivity DEMAYO, FRANCESCO BAYLOR COLLEGE OF MEDICINE TX $303,930
Uterine Cancer 2010 NCI 1R21CA143331-01 Progesterone Contrast Agents for MRI MEADE, THOMAS NORTHWESTERN UNIVERSITY IL $174,497
Uterine Cancer 2010 NCI 5R03CA135632-02 Type 1 and Type 2 Endometrial Cancer: Have They Different Risk Factors? A Pooled SETIAWAN, VERONICA UNIVERSITY OF SOUTHERN CALIFORNIA CA $81,125
Uterine Cancer 2010 NICHD 7R01HD042280-06 Modulation of the Receptive Endometrium by CG FAZLEABAS, ASGERALLY MICHIGAN STATE UNIVERSITY MI $312,246
Uterine Cancer 2010 NICHD 5R01HD057873-03 Steroid Hormone Regulation of Uterine Function and Dysfunction JEONG, JAE-WOOK BAYLOR COLLEGE OF MEDICINE TX $258,341
Uterine Cancer 2010 NCI 1R01CA137181-01A2 Mouse Models and Translational Studies of Endometrial Cancer CASTRILLON, DIEGO UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $328,888
Uterine Cancer 2010 NCI 5R01CA097097-07 PTEN and the molecular genetics of endometrial cancer DI CRISTOFANO, ANTONIO ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $334,341
Uterine Cancer 2010 NCI 5R01CA133117-02 Role of the Mullerian Tract in Ovarian Cancer Development DUBEAU, LOUIS UNIVERSITY OF SOUTHERN CALIFORNIA CA $336,841
Uterine Cancer 2010 NCI 5R01CA128571-03 Embryonic Stem Cell Properties in Cancer MERRILL, BRADLEY UNIVERSITY OF ILLINOIS AT CHICAGO IL $318,641
Uterine Cancer 2010 NCI 5R01CA127731-03 Development of GPR30-Selective Ligands PROSSNITZ, ERIC UNIVERSITY OF NEW MEXICO NM $310,051
Uterine Cancer 2010 NCI 5R21CA140939-02 Uterine In-vivo Strain Imaging Using Saline Infusion VARGHESE, TOMY UNIVERSITY OF WISCONSIN MADISON WI $163,350
Uterine Cancer 2010 NIEHS 1R01ES018841-01 Dietary and Environmental Exposure to Cadmium and the Risk of Endometrial Cancer RULL, RUDOLPH CANCER PREVENTION INSTIT OF CALIFORNIA CA $273,843
Uterine Cancer 2010 NCI 2U10CA027469-30 Gynecologic Oncology Group DISAIA, PHILIP GYNECOLOGIC ONCOLOGY GROUP MD $8,224,605
Uterine Cancer 2010 NCI 5K07CA117979-05 Inflamation and the Risk of Endometrial Cancer VISWANATHAN, AKILA DANA-FARBER CANCER INSTITUTE MA $134,490
Uterine Cancer 2010 NCI 5R01CA095427-07 Mouse Model of Endometrial Tumorigenesis ELLENSON, LORA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $330,513
Uterine Cancer 2010 NCI 5R01CA140690-02 Dissecting the Mechanisms of Tamoxifen Action RATNAM, MANOHAR UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS OH $310,835
Uterine Cancer 2010 NCRR 5K26RR024196-04 Mentoring and Research in Mouse Models of Cancer and Infertility CASTRILLON, DIEGO UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $125,942
Uterine Cancer 2010 NCI 5R01CA125427-03 Extranuclear estrogen receptor actions on endometrial cancer cell proliferation JACKSON, TWILA UNIVERSITY OF COLORADO DENVER CO $285,728
Uterine Cancer 2010 NCI 5U01CA141576-02 LKB1 tumor suppressor and human cancer CASTRILLON, DIEGO UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $829,961
Uterine Cancer 2010 NCI 5R01CA133010-02 Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence GUNTER, MARC ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $597,346
Uterine Cancer 2010 NCI 5K01CA134550-04 Determinants of Exercise Adherence for Hispanic Cancer Survivor HUGHES, DANIEL UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $120,303
Uterine Cancer 2010 NCI 5R01CA132829-03 Validation and extension of the PREMM Model for mismatch repair gene mutations SYNGAL, SAPNA DANA-FARBER CANCER INSTITUTE MA $402,586
Uterine Cancer 2010 NCI 5R01CA099908-08 Targeted Therapy for Endometrial Cancer LESLIE, KIMBERLY UNIVERSITY OF IOWA IA $296,254
Uterine Cancer 2010 NCI 5R03CA143610-02 Uterine cancer survival disparities, Hispanic ethnicity, and comorbidities. COOK, LINDA UNIVERSITY OF NEW MEXICO NM $75,292
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7780 Metformin for the Chemoprevention of Endometrial Cancer In Obese, Insulin-Resista LU, KAREN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $972,872
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7829 Strategy for the Incorporation of Tissue Biomarkers in the Clinical Management of BROADDUS, RUSSELL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $207,334
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7849 EphA2 Targeting in Uterine Carcinoma SOOD, ANIL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $189,134
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7851 Targeting the PI3K Signaling Pathway in Endometrial Carcinoma HENNESSY, BRYAN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $189,306
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7852 Administrative Core LU, KAREN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $121,450
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7853 Pathology Core BROADDUS, RUSSELL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $94,150
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7854 Biomarkers Core LOOSE, DAVID UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $223,750
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7855 Biostatistics and Bioinformatics Core MUELLER, PETER UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $122,764
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7856 Developmental Research Program BURKE, THOMAS UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $89,620
Uterine Cancer 2010 NCI 2P50CA098258-06A2 7857 Career Development Program STANCEL, GEORGE UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $89,620
Uterine Cancer 2010 NICHD 1R21HD066297-01 Functional Analysis of Endometrial Stem/Progenitor Cells PRU, JAMES WASHINGTON STATE UNIVERSITY WA $214,118
Uterine Cancer 2010 NCCAM 1R21AT005377-01A1 Identification of novel phytoprogestins from hops and red clover BURDETTE, JOANNA UNIVERSITY OF ILLINOIS AT CHICAGO IL $1
Uterine Cancer 2010 OD 1R21AT005377-01A1 Identification of novel phytoprogestins from hops and red clover BURDETTE, JOANNA UNIVERSITY OF ILLINOIS AT CHICAGO IL $235,499
Uterine Cancer 2010 NCI 1K23CA143154-01A1 Metformin as a Novel Chemotheraeutic Strategy for the Treatment of Endometrial Ca BAE-JUMP, VICTORIA UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $170,873
Uterine Cancer 2010 NCI 1R01CA148747-01A1 Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer CLIBY, WILLIAM MAYO CLINIC MN $163,614
Uterine Cancer 2010 NIA 1F31AG034813-01A1 Epigenetic Molecular Mechanisms and Reproductive Transitions WALKER, DEENA UNIVERSITY OF TEXAS AUSTIN TX $30,647
Uterine Cancer 2010 NCI 2R13CA113095-06 Annual Uterine Cancer Biology Symposium LU, KAREN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $10,000
Uterine Cancer 2010 NICHD 5U54HD007495-37 6899 PROJECT 3 - MicroRNAs in Endometrial Function and Dysfunction MATZUK, MARTIN BAYLOR COLLEGE OF MEDICINE TX $243,372
Uterine Cancer 2010 NICHD 5U54HD058155-02 7071 PROJECT 1 - Estrogen and Progesterone Regulation of Human Endometrial Cell Prolif POLLARD, JEFFREY ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $537,052
Uterine Cancer 2010 NCI 5U54CA096297-08 0011 Pilot Project A MADSEN, LINDA UNIVERSITY OF PUERTO RICO PR $112,816
Uterine Cancer 2010 NCI 3R01CA137181-01A2S1 Mouse Models and Translational Studies of Endometrial Cancer CASTRILLON, DIEGO UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $36,165
Uterine Cancer 2010 NHGRI 1ZIAHG200338-04 Genomic Analyses of Endometrial Cancer BELL, DAPHNE NIH $1,048,895
Uterine Cancer 2010 NCI 1ZIABC005177-30 Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA POIRIER, MIRIAM NIH $832,354
Uterine Cancer 2010 NCI 1ZIABC010797-04 Mechanisms of Stromal Cell Activation by the Developing Tumor NIEDERHUBER, JOHN NIH $534,303
Uterine Cancer 2010 NCI 1ZIABC011315-01 Molecular characterization of endometrial cancer ANNUNZIATA, CHRISTINA NIH $63,998
Uterine Cancer 2010 NCI 1ZIACP010126-15 Hormone-Related Cancers BRINTON, LOUISE NIH $2,546,989
Uterine Cancer 2010 NCRR 5M01RR000847-37 7030 IMPACT OF OBESITY AND PHYSICAL ACTIVITY ON ENDOMETRIAL CANCER GENESIS MODESITT, SUSAN UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $24,056
Uterine Cancer 2010 NHGRI 1ZICHG200348-03 NHGRI/DIR Cytogenetics and Microscopy Core BIESECKER, LESLIE NIH $1,090,671
Uterine Cancer 2010 NCI 1ZIEBC011136-02 The CCRWalter Reed Army Medical Center (WRAMC) Gynecologic Cancer Program Resear KOHN, ELISE NIH $95,611
Uterine Cancer 2010 NCI 2P30CA091842-09 6588 Translational and Clinical Research MOLEY, JEFFREY WASHINGTON UNIVERSITY MO $7,865
Uterine Cancer 2010 NCI 5P50CA134254-02 7898 FGFR2 as a Therapeutic Target in Endometrial Cancer. POLLOCK, PAMELA WASHINGTON UNIVERSITY MO $156,607
Uterine Cancer 2010 NCI 5P50CA134254-02 7899 Methylation Markers for Prognosis in Endometriod Endometrial Cancers HUANG, TIM OHIO STATE UNIVERSITY OH $152,900
Uterine Cancer 2010 NCI 5P50CA134254-02 7900 Identifying inherited endometrial cancer & the environmental and genetic factors GOODFELLOW, PAUL WASHINGTON UNIVERSITY MO $190,493


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer